Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179439 · ClinicalTrials.gov registry record
NPDT Evaluation in Children With CFTR and (PSC)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT00179439: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT00179439 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179439 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The investigators hypothesize that PSC in children is associated with mutations and functional changes of the cystic fibrosis (CF) gene.
Interventions
- PROCEDURE nasal potential difference testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-01 |
What the finished NCT00179439 record still lists
NCT00179439 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which nasal potential difference testing is the first listed.
NCT00179439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179439 about?
NCT00179439 is a clinical study titled "NPDT Evaluation in Children With CFTR and (PSC)". The investigators hypothesize that PSC in children is associated with mutations and functional changes of the cystic fibrosis (CF) gene.
What is the current status of trial NCT00179439?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2004-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00179439?
The interventions under investigation include: nasal potential difference testing (PROCEDURE).
Who is sponsoring clinical trial NCT00179439?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia